SE358397B - - Google Patents

Info

Publication number
SE358397B
SE358397B SE15037/69A SE1503769A SE358397B SE 358397 B SE358397 B SE 358397B SE 15037/69 A SE15037/69 A SE 15037/69A SE 1503769 A SE1503769 A SE 1503769A SE 358397 B SE358397 B SE 358397B
Authority
SE
Sweden
Application number
SE15037/69A
Inventor
W Hepworth
G Stacey
Original Assignee
Ici Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ici Ltd filed Critical Ici Ltd
Publication of SE358397B publication Critical patent/SE358397B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/30Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE15037/69A 1965-10-07 1966-10-06 SE358397B (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB42635/65A GB1099389A (en) 1965-10-07 1965-10-07 Pharmaceutical compositions
GB1749666 1966-04-21
GB2686266 1966-06-16

Publications (1)

Publication Number Publication Date
SE358397B true SE358397B (es) 1973-07-30

Family

ID=27257509

Family Applications (3)

Application Number Title Priority Date Filing Date
SE15037/69A SE358397B (es) 1965-10-07 1966-10-06
SE15036/69A SE364049B (es) 1965-10-07 1966-10-06
SE13513/66A SE346112B (es) 1965-10-07 1966-10-06

Family Applications After (2)

Application Number Title Priority Date Filing Date
SE15036/69A SE364049B (es) 1965-10-07 1966-10-06
SE13513/66A SE346112B (es) 1965-10-07 1966-10-06

Country Status (11)

Country Link
US (2) US3538107A (es)
BE (1) BE687981A (es)
CH (1) CH515922A (es)
DE (1) DE1695252A1 (es)
DK (1) DK112733B (es)
ES (1) ES331997A1 (es)
FR (2) FR1509969A (es)
GB (1) GB1099389A (es)
IL (1) IL26603A (es)
NL (2) NL6614130A (es)
SE (3) SE358397B (es)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3546342A (en) * 1966-11-18 1970-12-08 Wyeth John & Brother Ltd Method of relieving inflammation by administration of 2,4 - diarylthiazole- 5 - alkanoic acids and derivatives thereof
GB1145884A (en) * 1966-11-18 1969-03-19 Wyeth John & Brother Ltd Thiazole derivatives
IL28803A (en) * 1966-11-18 1974-05-16 Wyeth John & Brother Ltd Oxazole and thiazole compounds,their preparation and pharmaceutical compositions containing them
IE32084B1 (en) * 1967-06-07 1973-04-04 Wyeth John & Brother Ltd Thiazole derivatives
GB1237194A (en) * 1967-10-26 1971-06-30 Wyeth John & Brother Ltd Pharmaceutical compositions containing 2-arylthiazoles
CY800A (en) * 1968-04-09 1976-12-01 Wyeth John & Brother Ltd Novel thiazoline derivatives, the preparation thereof and compositions containing the same
FR2035757A1 (en) * 1969-02-25 1970-12-24 Roussel Uclaf Novel 4-carboxy-4,5,6,7-tetrahydro benzothia- - zole derivs
US3898340A (en) * 1970-04-15 1975-08-05 Bayer Ag Aryliminothiazolidine compositions and methods
FR2334353A1 (fr) * 1975-12-12 1977-07-08 Roussel Uclaf Nouveaux derives thiazoliques, un procede pour leur preparation et leur application comme medicaments
US4153703A (en) * 1977-06-30 1979-05-08 Uniroyal, Inc. Method of controlling insects and acarids with certain aryl-substituted thiazoles
US4197306A (en) * 1977-06-30 1980-04-08 Uniroyal, Inc. Aryl-substituted thiazoles
GR74148B (es) * 1980-04-03 1984-06-06 Wyeth John & Brother Ltd
FR2500452A1 (fr) * 1981-02-26 1982-08-27 Roussel Uclaf Alcools heterocycliques et derives fonctionnels, ainsi que leur procede de preparation
US4600025A (en) * 1982-11-18 1986-07-15 Grigg Ronald E Smoking products comprising nicotine substitutes
US5182402A (en) * 1988-11-07 1993-01-26 Imperial Chemical Industries Plc Herbicidal compositions
GB8826035D0 (en) * 1988-11-07 1988-12-14 Ici Plc Herbicidal compositions
DE3941438A1 (de) * 1989-12-15 1991-06-20 Hoechst Ag Neue 2-substituierte 4-(3-alkyl-5-tert.-butyl-4-hydroxy-phenyl)-thiazole, verfahren zu ihrer herstellung, die sie enthaltenden arzneimittel und ihre verwendung
US5077305A (en) * 1990-02-13 1991-12-31 Bristol-Myers Squibb Co. Thiazole carboxylic acids and esters
CA2036192A1 (en) 1990-02-13 1991-08-14 Nicholas Meanwell Heterocyclic carboxylic acids and esters
US5498678A (en) * 1992-12-21 1996-03-12 Rohm And Haas Company Suspension polymerization process for water-soluble monomers
US5451397A (en) * 1992-12-21 1995-09-19 Rohm And Haas Company Bile acid sequestrant
DE10029077A1 (de) * 2000-06-13 2001-12-20 Bayer Ag Thiazolylsubstituierte Heterocyclen
DE10100175A1 (de) * 2001-01-04 2002-07-11 Bayer Ag Hetarylsubstituierte Homotetram-und Homotetronsäuren
DE10118310A1 (de) * 2001-04-12 2002-10-17 Bayer Ag Hetarylsubstituierte carbocyclische 1,3-Dione
JP4073786B2 (ja) * 2001-04-16 2008-04-09 田辺三菱製薬株式会社 高コンダクタンス型カルシウム感受性kチャネル開口薬
US6916627B2 (en) * 2002-11-27 2005-07-12 St. Jude Children's Research Hospital ATM kinase compositions and methods
DE10331675A1 (de) 2003-07-14 2005-02-10 Bayer Cropscience Ag Hetarylsubstituierte Pyrazolidindion-Derivate
EP1787986A4 (en) * 2004-08-10 2007-08-22 Shizuoka Coffein Co Ltd HYDROXAMINE ACID DERIVATIVE AND MEDICAMENT THEREFORE AS AN ACTIVE COMPONENT
MA37975B2 (fr) 2012-09-11 2021-03-31 Genzyme Corp Inhibiteurs de synthase de glucosylcéramide
EP2970251B1 (en) * 2013-03-15 2019-02-27 Genzyme Corporation Method of preparing glucosylceramide synthase inhibitors
US11091451B2 (en) * 2016-12-05 2021-08-17 Raze Therapeutics, Inc. SHMT inhibitors and uses thereof
US20190298702A1 (en) * 2018-03-29 2019-10-03 Lumosa Therapeutics Co., Ltd. Compositions and methods for treating pruritus
BR112020022016A2 (pt) * 2018-04-27 2021-02-23 Ahammune Biosciences Private Limited processo para preparação de um composto de tiazol potente, formulação farmacêutica e seus usos
GB2581502A (en) * 2019-02-19 2020-08-26 Univ Bristol Solidification or crystallisation method
AU2021215396A1 (en) 2020-02-03 2022-09-29 Genzyme Corporation Methods for treating neurological symptoms associated with lysosomal storage diseases
US11857512B2 (en) 2020-07-24 2024-01-02 Genzyme Corporation Pharmaceutical compositions comprising venglustat

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2020650A (en) * 1932-08-18 1935-11-12 Winthrop Chem Co Inc Thiazole substituted by a primary alkylamino group

Also Published As

Publication number Publication date
FR6190M (es) 1968-07-22
NL130759C (es)
FR1509969A (fr) 1968-01-19
SE346112B (es) 1972-06-26
US3538107A (en) 1970-11-03
DE1695252A1 (de) 1971-03-18
SE364049B (es) 1974-02-11
BE687981A (es) 1967-04-07
GB1099389A (en) 1968-01-17
CH515922A (de) 1971-11-30
US3749787A (en) 1973-07-31
NL6614130A (es) 1967-04-10
DK112733B (da) 1969-01-13
ES331997A1 (es) 1967-10-16
IL26603A (en) 1970-11-30

Similar Documents

Publication Publication Date Title
FI44715B (es)
FR6190M (es)
FR1573817A (es)
AT279638B (es)
JPS442387Y1 (es)
AU5279364A (es)
JPS4532493Y1 (es)
JPS4313651Y1 (es)
JPS4314594Y1 (es)
JPS4419704Y1 (es)
JPS4421847Y1 (es)
JPS451937Y1 (es)
BE676254A (es)
NL6607280A (es)
NL6605956A (es)
BE675793A (es)
AU408104B2 (es)
BE675550A (es)
BE660801A (es)
BE663495A (es)
BE663749A (es)
BE663947A (es)
NL6612837A (es)
BE664336A (es)
BE685679A (es)